Sort by
Refine Your Search
-
therapeutic strategy using genetically engineered MSCs to provide novel treatment options for two rare ocular surface diseases leading progressively to blindness. The project is funded by AFM-Téléthon and
Enter an email to receive alerts for afm "https:" positions